Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.44 |
| ▸ | POLRMT | O00411 | 1/20 | 0.34 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16710856 | 0.91 | TMPRSS2 (0.51) | TMPRSS2POLRMT | |
| SCHEMBL16710418 | 0.91 | TMPRSS2 (0.51) | TMPRSS2POLRMT | |
| SCHEMBL25385813 | 0.89 | TMPRSS2 (0.42) | TMPRSS2POLRMT | |
| SCHEMBL26823086 | 0.86 | TMPRSS2 (0.40) | TMPRSS2POLRMT | |
| SCHEMBL23803200 | 0.84 | TMPRSS2 (0.38) | TMPRSS2 | |
| SCHEMBL19768739 | 0.82 | POLRMT (0.46) | TMPRSS2POLRMTDOT1L | |
| SCHEMBL19779087 | 0.82 | POLRMT (0.46) | TMPRSS2POLRMTDOT1L | |
| SCHEMBL16708508 | 0.82 | POLRMT (0.46) | TMPRSS2POLRMTDOT1L | |
| Hydrochloric Acid SCHEMBL25392678 | 0.81 | POLRMT (0.45) | TMPRSS2POLRMTDOT1L | |
| Hydrochloric Acid SCHEMBL25392672 | 0.80 | POLRMT (0.45) | TMPRSS2POLRMTDOT1L |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230382940-A1 | ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | GILEAD SCIENCES, INC. | 2023-11-30 | — | — | US | disclosed |
| WO-2023168254-A1 | ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | GILEAD SCIENCES, INC. (US) | 2023-09-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230382940-A1 | ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | EIF2AK2, MAVS, ZC3HAV1 | TMPRSS2 553/4885POLRMT 13/4885DOT1L 2954/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.